血清外泌体来源的microRNA-221-3p在肝细胞癌中的表达及意义

吴俊艺; 赖智德; 田毅峰; 王耀东

doi:10.3969/j.issn.1001-5256.2020.08.018

血清外泌体来源的microRNA-221-3p在肝细胞癌中的表达及意义

DOI: 10.3969/j.issn.1001-5256.2020.08.018

1. 福建省立医院肝胆胰外科
2. 南京大学医学院附属南京鼓楼医院肝胆胰外科

基金项目:

福建医科大学启航基金(2018QH1112)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1243
- HTML全文浏览量: 38
- PDF下载量: 205
- 被引次数: 0
出版历程
- 出版日期: 2020-08-20

Expression and clinical significance of serum exosomal microRNA-221-3p in hepatocellular carcinoma

Department of Hepatobiliary Surgery, Fujian Provincial Hospital

Research funding:

摘要

摘要:
目的探讨肝细胞癌（HCC）患者血清外泌体来源microRNA（miRNA）-221-3p的表达水平及分析其临床意义。方法选取2010年2月-2014年12月南京大学医学院附属南京鼓楼医院经手术治疗后诊断为HCC的66例患者作为HCC组,选取25例同期在本院接受健康检查的体检者作为对照组。通过外泌体提取试剂盒分离HCC组和对照组血清中的外泌体,采用蛋白免疫印迹检测外泌体标记蛋白分子,透射电镜鉴定血清外泌体形态;实时荧光定量PCR方法检测两组血清外泌体来源的miRNA-221-3p表达水平。计量资料两组间比较采用Mann-Whitney U检验,计数资料两组间比较采用χ2检验。采用Kaplan-Meier方法及logrank检验分析血清外泌体来源的miRNA-221-3p表达与预后关系,采用Cox比例风险回归模型分析预后影响因素。结果血清来源的外泌体是直径为40～100 nm囊泡体,表达HSP70、Alix及CD63。HCC组血清来源外泌体中miRNA-221-3p较对照组表达水平升高,差异具有统计学意义（U=354.00,P<0.001）。HCC患者血清外泌体...
- 癌,肝细胞 /
- 外泌体 /
- 微RNAs /
- 预后
Abstract:
Objective To investigate the expression and clinical significance of serum exosomal microRNA(miRNA)-221-3 p in hepatocellular carcinoma(HCC).Methods A total of 66 patients who underwent surgery in Nanjing Drum Tower Hospital,Nanjing University Medical School,from February 2010 to December 2014 and were diagnosed with HCC were enrolled as HCC group,and 25 individuals who underwent physical examination in our hospital during the same period of time were enrolled as control group.The exosome extraction kit was used to isolate the exosomes in serum;Western blotting was used to measure the expression of exosome markers;a transmission electron microscope was used to observe the morphology of serum exosomes;quantitative real-time PCR was used to measure the expression of serum exosomal miRNA-221-3 p.The Mann-Whitney U test was used for comparison of continuous data between two groups,and the chi-square test was used for comparison of categorical data between two groups.The Kaplan-Meier method and the log-rank test were used to analyze the association of the expression of serum exosomal miRNA-221-3 p with prognosis,and the Cox proportional hazards regression model was used to analyze the influencing factors for prognosis.Results Serum exosomes were small membranous vesicles with a diameter of about 40-100 nm,and HSP70,Alix,and CD63 were expressed in the exosomes.The HCC group had significantly higher expression of serum exosomal miRNA-221-3 p than the control group(U=354.00,P<0.001).In the patients with HCC,the high expression of serum exosomal miRNA-221-3 p was associated with tumor size(χ2=6.016,P=0.014),capsular invasion(χ2=7.580,P=0.006),and TNM stage(χ2=6.340,P=0.012).In addition,the HCC patients with high expression of serum exosomal miRNA-221-3 p had a significantly lower overall survival rate than those with low expression(χ2=17.105,P<0.001).The multivariate analysis showed that the expression of serum exosomal miRNA-221-3 p(hazard ratio [HR]=2.434,95% confidence interval [CI]:1.178-5.027,P=0.016)and tumor stage(HR=2.653,95% CI:1.222-5.760,P=0.014) were independent risk factors for the prognosis of patients with HCC.Conclusion There is a significant increase in the expression of serum exosomal miRNA-221-3 p in HCC patients,which provides a reference for the diagnosis and prognostic evaluation of HCC.
- carcinoma,hepatocellular /
- exosomes /
- microRNAs /
- prognosis

HTML全文

参考文献(17)

[1] CHEN WQ,ZHENG RS,BAADE PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.

[2] CLARK T,MAXIMIN S,MEIER J,et al. Hepatocellular carcinoma:Review of epidemiology,screening,imaging diagnosis,response assessment,and treatment[J]. Curr Probl Diagn Radiol,2015,44(6):479-486.

[3] MA WJ,WANG HY,TENG LS. Correlation analysis of preoperative serum alpha-fetoprotein(AFP)level and prognosis of hepatocellular carcinoma(HCC)after hepatectomy[J]. World J Surg Oncol,2013,11:212.

[4] XU YB,CUI HM,XUE F,et al. Progress in study on the role of exsomes-derived microRNA in diagnosis of CRC[J]. Chin J Oper Proc Gen Surg,2016,12(6):535-537.(in Chinese)徐玉彬，崔恒宓，薛峰，等．外泌体源性miRNA与结直肠癌诊断的研究进展[J]．中华普外科手术学杂志，2016,12(6):535-537.

[5] ZHANG C,MENG D,ZHANG BY,et al. Research advances in exosomes in diagnosis of pancreatic cancer[J]. J Clin Hepatol,2019,35(5):1165-1167.(in Chinese)张程，孟迪，张禀业，等．外泌体在胰腺癌诊断中的作用[J]．临床肝胆病杂志，2019,35(5):1165-1167.

[6] National Health and Family Planning Commission of the People’s Repubilc of China. Diagnosis,management,and treatment of hepatocellular carcinoma(V2017)[J]. J Clin Hepatol,2017,33(8):1419-1431.(in Chinese)中华人民共和国国家卫生和计划生育委员会．原发性肝癌诊疗规范(2017年版)[J]．临床肝胆病杂志，2017,33(8):1419-1431.

[7] EL ANDALOUSSI S,MGER I,BREAKEFIELD XO,et al. Extracellular vesicles:Biology and emerging therapeutic opportunities[J]. Nat Rev Drug Discov,2013,12(5):347-357.

[8] SOHN W,KIM J,KANG SH,et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma[J]. Exp Mol Med,2015,47:e184.

[9] WANG L,MENG L,LIU SW,et al. Research progress in generation and biological functions of exosome[J]. J Jilin Univ(Med Edit),2018,44(5):1109-1114.(in Chinese)王璐，孟琳，刘树威，等．外泌体的产生及其生物学作用的研究进展[J]．吉林大学学报(医学版)，2018,44(5):1109-1114.

[10] TANAKA Y,KAMOHARA H,KINOSHITA K,et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma[J]. Cancer,2013,119(6):1159-1167.

[11] LV CY,DING WJ,WANG YL,et al. A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis[J]. Int Urol Nephrol,2018,50(5):973-982.

[12] LIU W,HU J,ZHOU K,et al. Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma[J]. Onco Targets Ther,2017,10:3843-3851.

[13] QU Z,WU J,WU J,et al. Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis[J]. Oncotarget,2017,8(46):80666-80678.

[14] ZHANG Y,TUO M,LIU SW. Vsalue of serum exosomes miRNA-122 detection in diagnosis of primary hepatocellular carcinoma[J].Lab Med Clin,2017,14(9):1260-1262.(in Chinese)张云，庹敏，刘胜武．血清外泌体来源的miR-122对肝癌诊断的研究[J]．检验医学与临床，2017,14(9):1260-1262.

[15] SUGIMACHI K,MATSUMURA T,HIRATA H,et al. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation[J]. Br J Cancer,2015,112(3):532-538.

[16] CUI Y,XU HF,LIU MY,et al. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value[J]. World J Gastroenterol,2019,25(15):1890-1898.

[17] SHI M,JIANG Y,YANG L,et al. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma[J]. J Cell Biochem,2018,119(6):4711-4716.

施引文献

资源附件(0)

访问统计